Kanokpan Wongprasert

10PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersMedical devicesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Fish physiology and genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 28, 2026
miR-1294 Upregulation as a Diagnostic Biomarker for Cholangiocarcinoma.

|Mar 28, 2026
Ethanolic Gracilaria fisheri Extract and Purified N-Benzylcinnamamide Inhibit Staphylococcus epidermidis Adhesion and Biofilm Formation on Device-Relevant Surfaces.

Kulwadee Karnjana, Sakun Thala, Kanokpan Wongprasert

|Jan 16, 2026
Preclinical development of mesothelin-targeting CAR T cells for the treatment of cholangiocarcinoma.

Jinchutha Duangdara, Shaoli Lin, Jessica Hong

|Feb 24, 2024
Therapeutic Implications of Ceritinib in Cholangiocarcinoma beyond ALK Expression and Mutation.

Kyaw Zwar Myint, Brinda Balasubramanian, Simran Venkatraman

|Jan 26, 2024
CP-673451, a Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces Apoptosis in Opisthorchis viverrini-Associated Cholangiocarcinoma via Nrf2 Suppression and Enhanced ROS.

Jinchutha Duangdara, Boonyakorn Boonsri, Apinya Sayinta

|May 13, 2023
Targeting FGFRs Using PD173074 as a Novel Therapeutic Strategy in Cholangiocarcinoma.

Brinda Balasubramanian, Kiren Yacqub-Usman, Simran Venkatraman

Pageof 2

Frequent Collaborators

4 joint publications

Tawut Rudtanatip

3 joint publications

Rutaiwan Tohtong

3 joint publications

David O Bates

3 joint publications

Tavan Janvilisri